Halfmann P - Search Results

1

Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction.

Westmark CJ, Kiso M, Halfmann P, Westmark PR, Kawaoka Y. Westmark CJ, et al. Among authors: halfmann p. Front Cell Dev Biol. 2020 Aug 26;8:856. doi: 10.3389/fcell.2020.00856. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32984339 Free PMC article.

2

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.

Hatta M, Gao P, Halfmann P, Kawaoka Y. Hatta M, et al. Among authors: halfmann p. Science. 2001 Sep 7;293(5536):1840-2. doi: 10.1126/science.1062882. Science. 2001. PMID: 11546875

3

Human influenza a viral genes responsible for the restriction of its replication in duck intestine.

Hatta M, Halfmann P, Wells K, Kawaoka Y. Hatta M, et al. Among authors: halfmann p. Virology. 2002 Apr 10;295(2):250-5. doi: 10.1006/viro.2002.1358. Virology. 2002. PMID: 12033783 Free article.

4

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y. Kobasa D, et al. Among authors: halfmann p. Nature. 2004 Oct 7;431(7009):703-7. doi: 10.1038/nature02951. Nature. 2004. PMID: 15470432

5

Characterization of a human H5N1 influenza A virus isolated in 2003.

Shinya K, Hatta M, Yamada S, Takada A, Watanabe S, Halfmann P, Horimoto T, Neumann G, Kim JH, Lim W, Guan Y, Peiris M, Kiso M, Suzuki T, Suzuki Y, Kawaoka Y. Shinya K, et al. Among authors: halfmann p. J Virol. 2005 Aug;79(15):9926-32. doi: 10.1128/JVI.79.15.9926-9932.2005. J Virol. 2005. PMID: 16014953 Free PMC article.

6

Regions in Ebola virus VP24 that are important for nucleocapsid formation.

Noda T, Halfmann P, Sagara H, Kawaoka Y. Noda T, et al. Among authors: halfmann p. J Infect Dis. 2007 Nov 15;196 Suppl 2:S247-50. doi: 10.1086/520596. J Infect Dis. 2007. PMID: 17940956

7

Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.

Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y. Watanabe S, et al. Among authors: halfmann p. J Infect Dis. 2007 Nov 15;196 Suppl 2:S284-90. doi: 10.1086/520582. J Infect Dis. 2007. PMID: 17940962

8

Generation of biologically contained Ebola viruses.

Halfmann P, Kim JH, Ebihara H, Noda T, Neumann G, Feldmann H, Kawaoka Y. Halfmann P, et al. Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1129-33. doi: 10.1073/pnas.0708057105. Epub 2008 Jan 22. Proc Natl Acad Sci U S A. 2008. PMID: 18212124 Free PMC article.

9

Replication-deficient ebolavirus as a vaccine candidate.

Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S, Suresh M, Neumann G, Feldmann H, Kawaoka Y. Halfmann P, et al. J Virol. 2009 Apr;83(8):3810-5. doi: 10.1128/JVI.00074-09. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211761 Free PMC article.

10

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. Nanbo A, et al. Among authors: halfmann p. PLoS Pathog. 2010 Sep 23;6(9):e1001121. doi: 10.1371/journal.ppat.1001121. PLoS Pathog. 2010. PMID: 20886108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters